Cargando…
miR-378d suppresses malignant phenotype of ESCC cells through AKT signaling
BACKGROUND: Post-resistance progress in paclitaxel (PTX) treatment remains a major challenge in tumor treatment. A high dose of PTX was used for cell lines to analyze the changes in molecular expression. The miR-378d was sharply reduced in surviving cells, but the role of miR-378d in Esophageal squa...
Autores principales: | Peng, Jie, Shi, Susu, Yu, Juan, Liu, Jianli, Wei, Haixiang, Song, Haixia, Wang, Shaoqiang, Li, Zhejie, He, Shujin, Li, Lei, Zhang, Hongyan, Yan, Zhizhen, Zhao, Ran, Liu, Yukun, Liu, Yanrong, Li, Junjun, Zhang, Renya, Wang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8697470/ https://www.ncbi.nlm.nih.gov/pubmed/34937563 http://dx.doi.org/10.1186/s12935-021-02403-y |
Ejemplares similares
-
High expression of SDC1 in stromal cells is associated with good prognosis in colorectal cancer
por: Li, Zhejie, et al.
Publicado: (2023) -
DEPDC1B collaborates with GABRD to regulate ESCC progression
por: Yuan, Yunfeng, et al.
Publicado: (2022) -
circ_NRIP1 is oncogenic in malignant development of esophageal squamous cell carcinoma (ESCC) via miR-595/SEMA4D axis and PI3K/AKT pathway
por: Zhou, Shifan, et al.
Publicado: (2021) -
MicroRNA-378-5p suppresses cell proliferation and induces apoptosis in colorectal cancer cells by targeting BRAF
por: Wang, Zhenlei, et al.
Publicado: (2015) -
SH2B1 promotes NSCLC cell proliferation through PI3K/Akt/mTOR signaling cascade
por: Wang, Shaoqiang, et al.
Publicado: (2018)